Biomea Fusion is trading 14.6% up at $0.96, with no clear catalyst identified for the October 16, 2026 move. - The latest major company news was Phase 1 BMF-650 data announced October 13; coverage reported shares fell after the readout, which does not clearly explain this rebound. - XBI is down 2.06%, so sector strength does not account for the gain. No clear same-direction market or company catalyst was identified.